Assignee
SCYNEXIS INC
US10 patents
Top patents by PatentIndex Score
US7718767B2May 18, 2010
3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
SCYNEXIS INC20 citations89
US7196161B2Mar 27, 2007
3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
SCYNEXIS INC24 citations89
US7754685B2Jul 13, 2010
Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection
SCYNEXIS INC11 citations82
US7576057B2Aug 18, 2009
Cyclic peptides
SCYNEXIS INC16 citations79
US10927142B2Feb 23, 2021
Salts and polymorphs of SCY-078
SCYNEXIS INC0 citations62
US10370406B2Aug 6, 2019
Salts and polymorphs of SCY-078
SCYNEXIS INC0 citations52
US11534433B2Dec 27, 2022
Antifungal agents with enhanced activity in acidic pH
SCYNEXIS INC1 citations51
US12594266B2Apr 7, 2026
Triterpenoid antifungals for the treatment or prevention of Pneumocystis spp. pneumonia
SCYNEXIS INC0 citations47
US6736975B2May 18, 2004
Method of separating compound(s) from mixture(s)
SCYNEXIS INC5 citations46
US11110102B2Sep 7, 2021
Antifungal agents used in combination
SCYNEXIS INC0 citations40